We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 7,204 results
  1. Intermedin1–53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis

    Intermedin (IMD), a paracrine/autocrine peptide, protects against cardiac fibrosis. However, the underlying mechanism remains poorly understood....

    Lin-Shuang Zhang, **-Sheng Zhang, ... Yong-Fen Qi in Inflammation
    Article 17 February 2022
  2. A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway

    The present work investigates the potential role of metformin nanoparticles (MTF-NPs) as a radio-protector against cardiac fibrosis and inflammation...

    Heba M. Karam, Dina M. Lotfy, ... Amira Abd-ElRaouf in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 09 April 2024
  3. Hederagenin protects against myocardial ischemia–reperfusion injury via attenuating ALOX5-mediated ferroptosis

    Hederagenin (HDG), a medical herb, is known for its beneficial activities against diverse diseases. The cardioprotective effect of HDG has been...

    Li Zhao, Hongtao Shi, ... Qinghua Han in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 13 November 2023
  4. Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis

    Both cancer and fibrosis are diseases involving dysregulation of cell signaling pathways resulting in an altered cellular microenvironment which...

    Alireza Baniasadi, Jeeban P. Das, ... Kathleen M. Capaccione in Journal of Translational Medicine
    Article Open access 13 June 2024
  5. PCSK9 Knockdown Can Improve Myocardial Ischemia/Reperfusion Injury by Inhibiting Autophagy

    This study investigates the effect and mechanism of proprotein convertase subtilisin/Kexin type 9 (PCSK9) on myocardial ischemia–reperfusion injury...

    Guangwei Huang, **yang Lu, ... Wei Li in Cardiovascular Toxicology
    Article 07 November 2022
  6. Modulation of anti-cardiac fibrosis immune responses by changing M2 macrophages into M1 macrophages

    Background

    Macrophages play a crucial role in the development of cardiac fibrosis (CF). Although our previous studies have shown that glycogen...

    Shiqi Chen, Kan Wang, ... Junwei Liu in Molecular Medicine
    Article Open access 15 June 2024
  7. Extracellular vesicles derived from human bone marrow mesenchymal stem cells protect rats against acute myocardial infarction-induced heart failure

    Extracellular vesicles (EVs) derived from human bone marrow mesenchymal stem cells (BMSCs) are suggested to promote angiogenesis in a rat model of...

    Liying Xuan, Danni Fu, ... Guohua Gong in Cell and Tissue Research
    Article 07 May 2022
  8. Concurrent vitamin D supplementation and exercise training improve cardiac fibrosis via TGF-β/Smad signaling in myocardial infarction model of rats

    Although the role of vitamin D in various types of disorders such as cancer and diabetes has been well recognized, its relation to cardiovascular...

    Mohammad Mehdipoor, Arsalan Damirchi, ... Parvin Babaei in Journal of Physiology and Biochemistry
    Article 11 January 2021
  9. Research progress on the mechanism of anti-myocardial infarction effect and clinical application of effective components of Salvia miltiorrhiza

    Salvia miltiorrhiza , a plant in the Labiatae family, is a traditional Chinese herb. The small molecular components in S. miltiorrhiza can be divided...

    **n Zhang, Zhiying Bian, ... Yuhong Liu in Medicinal Chemistry Research
    Article 30 December 2023
  10. sST2: A Bridge Between Sirt1/p53/p21 Signal-Induced Senescence and TGF-β1/Smad2/3 Regulation of Cardiac Fibrosis in Mouse Viral Myocarditis

    Soluble interleukin 1 receptor-like 1 (sST2) is a novel predictor of poor outcomes, which is involved in inflammatory response and fibrosis of...

    Jiajia Tan, **g Wei, Hongxiang Lu in Inflammation
    Article Open access 10 April 2023
  11. Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity

    Myocardial regeneration capacity declines during the first week after birth, and this decline is linked to adaptation to oxidative metabolism....

    E. Kankuri, P. Finckenberg, ... E. Mervaala in Experimental & Molecular Medicine
    Article Open access 03 April 2023
  12. Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration

    Background

    Neovascular age-related macular degeneration (nAMD), accounts for up to 90% of AMD-associated vision loss, ultimately resulting in the...

    Dandan Liu, **gxiao Du, ... **gfa Zhang in Journal of Neuroinflammation
    Article Open access 26 March 2024
  13. Mild therapeutic hypothermia upregulates the O-GlcNAcylation level of COX10 to alleviate mitochondrial damage induced by myocardial ischemia–reperfusion injury

    Objective

    Mild therapeutic hypothermia (MTH) is an important method for perioperative prevention and treatment of myocardial ischemia–reperfusion...

    Wei Deng, Yixuan Chen, ... Peng Yu in Journal of Translational Medicine
    Article Open access 22 May 2024
  14. Cardiac-specific deletion of BRG1 ameliorates ventricular arrhythmia in mice with myocardial infarction

    Malignant ventricular arrhythmia (VA) after myocardial infarction (MI) is mainly caused by myocardial electrophysiological remodeling. Brahma-related...

    **g Li, Zi-yue Ma, ... Rong Huo in Acta Pharmacologica Sinica
    Article 25 October 2023
  15. Knockdown of SOX9 alleviates tracheal fibrosis through the Wnt/β-catenin signaling pathway

    Abstract

    Trachealfibrosis is an important cause of tracheal stenosis without effective treatments, and new drug targets need to be developed. The role...

    Lei Gu, Anmao Li, ... Shuliang Guo in Journal of Molecular Medicine
    Article 03 October 2022
  16. LncRNA MALAT1 Regulates USP22 Expression Through EZH2-Mediated H3K27me3 Modification to Accentuate Sepsis-Induced Myocardial Dysfunction

    Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long non-coding RNA (lncRNA), has been confirmed to recruit enhancer of zeste 2...

    Hong Xu, Wei Ye, Baochang Shi in Cardiovascular Toxicology
    Article 20 June 2022
  17. Sphingosylphosphorylcholine alleviates pressure overload-induced myocardial remodeling in mice via inhibiting CaM-JNK/p38 signaling pathway

    Apoptosis plays a critical role in the development of heart failure, and sphingosylphosphorylcholine (SPC) is a bioactive sphingolipid naturally...

    Fang-fang Ren, Lin Zhao, ... Lei Li in Acta Pharmacologica Sinica
    Article 13 October 2023
  18. Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway

    Peritoneal dialysis (PD) is the mainstay of treatment for renal failure replacement therapy. Although PD has greatly improved the quality of life of...

    Yingwen Bai, Lulu Wang, ... Weihong Ge in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 13 April 2023
  19. Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

    Background

    Renal interstitial fibrosis (RIF) is a common pathway to end-stage renal disease regardless of the initial etiology. Currently, the...

    Yilin Tao, Chengyuan Tang, ... Ying Li in Molecular Medicine
    Article Open access 09 May 2023
Did you find what you were looking for? Share feedback.